Mark Jason Heath Ellison

Insider Reports History

Location
Santa Monica, CA
Signature
/s/ Mark Jason Heath Ellison
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Jason Heath Ellison:

Company Role Class Num Shares Value Price $ Report Date Ownership
OPIANT PHARMACEUTICALS, INC. Chief Development Officer Common Stock 0 $20.00 02 Mar 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Development Officer Common Stock 0 $20.00 02 Mar 2023 Indirect
OPIANT PHARMACEUTICALS, INC. Chief Development Officer Stock Option (right to buy) 0 $10.00 02 Mar 2023 Direct

Insider Reports Filed by Mark Jason Heath Ellison

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000138550823000067-ellison-mark-jason-heath-2023-03-02 OPIANT PHARMACEUTICALS, INC. 02 Mar 2023 8 -$608,620 4 Chief Development Officer 03 Mar 2023, 08:16
/report/000138550823000033-ellison-mark-jason-heath-2023-01-27 OPIANT PHARMACEUTICALS, INC. 27 Jan 2023 1 -$12,359 4 Chief Development Officer 31 Jan 2023, 15:21
/report/000138550823000022-ellison-mark-jason-heath-2023-01-09 OPIANT PHARMACEUTICALS, INC. 09 Jan 2023 1 -$9,474 4 Chief Development Officer 09 Jan 2023, 16:13
/report/000138550823000013-ellison-mark-jason-heath-2023-01-05 OPIANT PHARMACEUTICALS, INC. 05 Jan 2023 1 -$36,481 4 Chief Development Officer 05 Jan 2023, 16:07
/report/000138550822000104-ellison-mark-jason-heath-2022-06-27 OPIANT PHARMACEUTICALS, INC. 27 Jun 2022 1 $0 4 Chief Development Officer 29 Jun 2022, 16:07
/report/000138550822000011-ellison-mark-jason-heath-2022-01-04 OPIANT PHARMACEUTICALS, INC. 04 Jan 2022 1 $0 4 Chief Development Officer 05 Jan 2022, 15:19